Domestic pharmaceutical companies are catching up multinational ones in the KRW 600 billion domestic hyperlipidemia treatment market
In the hyperlipidemia treatment market, multinational and domestic pharmaceutical companies are having fierce competitions.
Last year, the size of the domestic hyperlipidemia treatment market was KRW 600 million (80% in the market are statin-type drugs), and the top 10 pharmaceutical companies a...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
